Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trial
| Image |  |
|---|---|
| Description | scientific article published on 01 January 2019 |
| Author/s |
author: François Raffi |
| Publication date | January 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |